Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.5101
-0.1299 (-20.30%)
Oct 7, 2025, 3:26 PM EDT
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $1.71 million as of October 7, 2025. Its market cap has decreased by -79.34% in one year.
Market Cap
1.71M
Enterprise Value
2.30M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.51
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 1.71M, a decrease of -98.69%. That is a compound annual growth rate of -45.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1.71M | -34.69% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | 46.34M | -35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |